Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mayo Clin Proc ; 75(2): 189-92, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10683660

RESUMO

Usual causes of intolerance to thyroxine sodium include coronary artery disease, advanced age, untreated adrenal insufficiency, and severe hypothyroidism. We describe 4 patients with iron deficiency anemia and primary hypothyroidism. After treatment with thyroxine sodium, these patients developed palpitations and feelings of restlessness, which necessitated discontinuation of the thyroid hormone. After the anemia was treated with ferrous sulfate for 4 to 7 weeks, they were able to tolerate thyroxine sodium therapy. Iron deficiency anemia coexisting with primary hypothyroidism results in a hyperadrenergic state. In such patients, we postulate that thyroid hormone administration causes palpitations, nervousness, and feelings of restlessness. Correction of any existing pronounced anemia in hypothyroid patients who are intolerant to thyroxine sodium therapy may result in tolerance to this agent.


Assuntos
Anemia Ferropriva/complicações , Anemia Ferropriva/tratamento farmacológico , Compostos Ferrosos/uso terapêutico , Hipotireoidismo/complicações , Hipotireoidismo/tratamento farmacológico , Tiroxina/efeitos adversos , Adulto , Anemia Ferropriva/metabolismo , Anemia Ferropriva/fisiopatologia , Feminino , Humanos , Hipotireoidismo/metabolismo , Hipotireoidismo/fisiopatologia , Resultado do Tratamento
2.
Environ Health Perspect ; 106(5): 261-6, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9647894

RESUMO

Cricket frogs (Acris crepitans) from several different sites in Illinois were collected to assess the effects of environmental contamination on the prevalence of intersex gonads. Of 341 frogs collected in 1993, 1994, and 1995, 2.7% were intersex individuals. There was no statistically significant relationship between the chemical compounds detected and cricket frog intersexuality. However, there was an association approaching significance (p = 0.07) between the detection of atrazine and intersex individuals. A comparison of reference sites with sites that had point polychlorinated biphenyl (PCB) and polychlorinated dibenzofuran (PCDF) contamination revealed a significant relationship between sex-ratio reversal and contamination with PCBs and PCDFs. The sex ratio of juvenile frogs studied from three sites with PCB and PCDF point contamination favored males over females, which was the opposite of the sex ratio in control ponds (p = 0.0007). The statistically significant correlation between organochlorine contamination and sex-ratio reversal suggests PCBs and PCDFs can influence cricket frog sexual differentiation. The current study suggests that in cricket frogs, sex ratios and the prevalence of intersex gonads are altered by environmental contamination.


Assuntos
Anuros/anatomia & histologia , Anuros/fisiologia , Transtornos do Desenvolvimento Sexual/epidemiologia , Poluentes Ambientais/farmacologia , Envelhecimento/fisiologia , Animais , Benzofuranos/farmacologia , Feminino , Masculino , Bifenilos Policlorados/farmacologia , Prevalência , Distribuição por Sexo
3.
Mayo Clin Proc ; 71(12): 1145-9, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8945484

RESUMO

OBJECTIVE: To characterize a disorder of episodes of flushing and increased levels of 5-hydroxyindoleacetic acid (5-HIAA) in men with secondary hypogonadism who respond to testosterone therapy. MATERIAL AND METHODS: We present detailed case reports of three male patients who had flushing, secondary hypogonadism, and increased urinary 5-HIAA levels and describe their clinical and laboratory features before and after treatment with testosterone. In addition, six male patients with hypogonadism (three with primary and three with secondary hypogonadism) without flushing were assessed. RESULTS: The three patients with flushing and secondary hypogonadism (serum total testosterone 5.45 +/- 0.63 nmol/L, free testosterone 89.3 +/- 7.0 pmol/L, follicle-stimulating hormone 3.85 +/- 0.58 IU/L, and luteinizing hormone 4.41 +/- 0.98 IU/L) had increased urinary 5-HIAA levels (98.5 +/- 12.2 micromol/24 h) but normal blood serotonin levels (9.66 +/- 1.58 micromol/L). During a pentagastrin-calcium stimulation test, serum calcitonin and blood serotonin values were normal in patients with secondary hypogonadism and flushing. Detailed investigation showed no evidence of a carcinoid tumor. Urinary 5-HIAA levels became normal (16.6 +/- 1.73 micromol/24 h) after treatment with testosterone. When testosterone therapy was discontinued in two patients, flushing and increased urinary 5-HIAA levels recurred. Furthermore, flushing and the elevated urinary 5-HIAA values resolved when testosterone treatment was reinitiated. The six patients with hypogonadism without flushing had normal urinary 5-HIAA levels (14.9 +/- 3.31 micromol/24 h). CONCLUSION: Male patients with flushing and increased urinary 5-HIAA levels should undergo assessment for hypogonadism after screening for carcinoid tumor. If hypogonadism is diagnosed, resolution of flushing and normalization of 5-HIAA may be achieved with testosterone treatment. We suggest that pseudocarcinoid syndrome associated with hypogonadism be the descriptive label used for this combination of clinical features.


Assuntos
Antineoplásicos Hormonais/uso terapêutico , Ácido Hidroxi-Indolacético/urina , Hipogonadismo/complicações , Hipogonadismo/tratamento farmacológico , Síndrome do Carcinoide Maligno/complicações , Síndrome do Carcinoide Maligno/tratamento farmacológico , Testosterona/uso terapêutico , Idoso , Rubor/complicações , Rubor/urina , Humanos , Hipogonadismo/urina , Masculino , Síndrome do Carcinoide Maligno/sangue , Síndrome do Carcinoide Maligno/urina , Pessoa de Meia-Idade , Serotonina/sangue , Testosterona/sangue
4.
Dent Clin North Am ; 40(3): 543-61, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8829045

RESUMO

Cardiovascular disease is the leading cause of death in the United States. Congestive heart failure (CHF) is often the result of many non-fatal heart problems. Many patients who suffer from heart failure die as a result of cardiac dysrhythmias. This article discusses the normal heart, the changes from normal seen in CHF and dysrhythmias, the medical management of these conditions, including medications used, and the implications for the dental management of these patients.


Assuntos
Arritmias Cardíacas/tratamento farmacológico , Insuficiência Cardíaca/tratamento farmacológico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Antiarrítmicos/uso terapêutico , Arritmias Cardíacas/fisiopatologia , Baixo Débito Cardíaco/tratamento farmacológico , Baixo Débito Cardíaco/fisiopatologia , Causas de Morte , Assistência Odontológica para Doentes Crônicos , Glicosídeos Digitálicos/uso terapêutico , Diuréticos/uso terapêutico , Coração/fisiologia , Insuficiência Cardíaca/fisiopatologia , Humanos
5.
Dent Clin North Am ; 40(3): 563-84, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8829046

RESUMO

Ischemic heart disease and contributing risk factors such as the hyperlipoproteinemic states affect a great percentage of the general population. Because these disease processes can effectively place patients at risk for a life-threatening event, every health care provider must be knowledgeable, disciplined to take a thorough medical history, and prepared for emergency situations that may arise in the clinical practice of dentistry. A proactive approach to identification of risk factors and to primary prevention of ischemic heart disease not only helps to lengthen and improve the quality of patient's lives, but also ensures that necessary modifications of treatment reflect each patient's medical and pharmacologic status.


Assuntos
Hiperlipoproteinemias/tratamento farmacológico , Isquemia Miocárdica/tratamento farmacológico , Fármacos Cardiovasculares/uso terapêutico , Assistência Odontológica para Doentes Crônicos , Emergências , Humanos , Hiperlipoproteinemias/diagnóstico , Hiperlipoproteinemias/fisiopatologia , Hiperlipoproteinemias/prevenção & controle , Hipolipemiantes/uso terapêutico , Anamnese , Isquemia Miocárdica/diagnóstico , Isquemia Miocárdica/fisiopatologia , Isquemia Miocárdica/prevenção & controle , Qualidade de Vida , Fatores de Risco
6.
J Nucl Med ; 37(5): 854-6, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8965161

RESUMO

UNLABELLED: We present an 83-yr-old woman with a history of renal insufficiency, diabetes and idiopathic purpura (ITP) who experienced recurrent hemorrhage from gastric antral vascular ectasias (GAVE). METHODS: Extensive evaluation consisting of barium small bowel series, colonoscopy, abdominal CT scan and visceral angiography excluded other causes of bleeding. RESULTS: After 99mTc-labeled red cell imaging to localize the bleeding to the antrum, an antrectomy was performed. Seven months postsurgery, the patient experienced no further hemorrhage. CONCLUSION: 99mTc-labeled red cell scans can be used for the diagnosis of GAVE.


Assuntos
Hemorragia Gastrointestinal/etiologia , Antro Pilórico/irrigação sanguínea , Idoso , Idoso de 80 Anos ou mais , Diabetes Mellitus Tipo 2/complicações , Diagnóstico Diferencial , Dilatação Patológica/complicações , Dilatação Patológica/diagnóstico por imagem , Eritrócitos , Feminino , Hemorragia Gastrointestinal/diagnóstico por imagem , Humanos , Púrpura Trombocitopênica Idiopática/complicações , Cintilografia , Insuficiência Renal/complicações , Tecnécio
7.
Mayo Clin Proc ; 70(6): 556-8, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7776715

RESUMO

OBJECTIVE: To evaluate the effects of nicotinic acid on serum thyroid hormone levels in the absence of systemic illness or hepatic dysfunction. DESIGN: We determined the effect of treatment with nicotinic acid on serum thyroid hormone levels in one female and four male patients (mean age, 44.4 years) with hyperlipidemia. MATERIAL AND METHODS: In the five study patients, we measured serum lipids in conjunction with serum thyroxine (T4), triiodothyronine (T3) resin uptake, T3, free T4, thyroid-stimulating hormone (TSH), and thyroxine-binding globulin before, during, and after treatment with nicotinic acid. RESULTS: Serum lipid levels responded appropriately to nicotinic acid treatment. Thyroid function studies done a mean of 1.3 years (range, 0.5 to 3.5) after initiation of nicotinic acid therapy (mean daily dose, 2.6 +/- 0.7 g) revealed significant decreases in serum levels of total T4 (21%), free T4 index (16%), T3 (13%), and thyroxine-binding globulin (23%) (P < 0.02), whereas no significant changes were noted in free T4, T3 resin uptake, and TSH levels. During the course of treatment, the patients, who were carefully questioned, had no symptoms of hypothyroidism. Hypothyroidism was further excluded in three patients who had a normal serum TSH response to administration of thyrotropin-releasing hormone. In two patients, measurements of thyroid function returned to pretreatment levels after discontinuation of nicotinic acid therapy. No patient had significant abnormalities in liver-associated enzymes or evidence of systemic illness during the course of treatment. CONCLUSION: These results suggest that nicotinic acid decreases serum thyroid hormone concentrations while maintaining a euthyroid state. This effect may be mediated through reduction in thyroxine-binding globulin, but other mechanisms may also be involved.


Assuntos
Hiperlipidemias/sangue , Niacina/farmacologia , Tireotropina/efeitos dos fármacos , Proteínas de Ligação a Tiroxina/efeitos dos fármacos , Tiroxina/efeitos dos fármacos , Adulto , Feminino , Humanos , Hiperlipidemias/tratamento farmacológico , Fígado/efeitos dos fármacos , Fígado/fisiologia , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Niacina/uso terapêutico , Testes de Função Tireóidea , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/fisiologia , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Tri-Iodotironina/efeitos dos fármacos
9.
Dig Dis Sci ; 27(2): 155-60, 1982 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7075410

RESUMO

Two patients are presented having lymphomatous involvement of the central nervous system in whom dysphagia was the predominant symptom. All indicated studies failed to reveal evidence of direct esophageal involvement, and the dysphagia improved during treatment of the neural component. Esophageal manometric studies revealed abnormalities of the striated muscle portion of the esophagus. These two case histories suggest that invasion of the central nervous system with lymphoma may produce abnormalities of the neuromuscular control of esophageal function resulting in dysphagia.


Assuntos
Doenças do Sistema Nervoso Central/complicações , Transtornos de Deglutição/etiologia , Linfoma/complicações , Adolescente , Doenças do Sistema Nervoso Central/fisiopatologia , Transtornos de Deglutição/fisiopatologia , Esôfago/fisiopatologia , Humanos , Linfoma/fisiopatologia , Masculino , Manometria , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...